Understanding diabetes complications in cystic fibrosis
Part of Digestive system, Eyes & vision, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at how long-term diabetes affects people with cystic fibrosis. It helps researchers understand complications and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have cystic fibrosis and be 12 years or older.
- You must have had cystic fibrosis-related diabetes for at least 5 years.
- You cannot have had an organ transplant.
- You cannot be pregnant at the start or during the study.
- You must not have certain heart or blood vessel conditions (e.g., irregular heart rhythm, blocked leg arteries).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
This trial studies whether changing eating habits—especially added sugar intake—affects health in adults with cystic fibrosis. It may help by testing a diet approach aimed at better outcomes related to metabolism and overall health.
This study looks at how the kidneys work in people with cystic fibrosis, especially those taking highly effective new treatments. It aims to understand kidney function in different groups, including those who are hospitalized frequently or rarely.
This study looks at how cystic fibrosis and gene modulator treatments affect the health of your heart and blood vessels. By joining, you'll help researchers understand these effects and potentially improve care for people with CF.
This study looks at genetic (inherited DNA) factors that may influence who develops diabetes related to cystic fibrosis. Your results could help doctors better predict risk and improve care for cystic fibrosis and related diabetes.
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
Hear when a new Cystic Fibrosis-related Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.